Mizuho Maintains Buy on Inspire Medical Systems, Lowers Price Target to $215
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone maintains a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) but has lowered the price target from $300 to $215.
November 08, 2023 | 8:22 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inspire Medical Systems' price target has been lowered from $300 to $215 by Mizuho, though the 'Buy' rating is maintained.
The news is directly about Inspire Medical Systems. The lowering of the price target might indicate a potential downside risk, but the maintained 'Buy' rating suggests Mizuho still sees value in the stock. This could lead to mixed market reactions in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100